Cargando…

Clozapine is associated with secondary antibody deficiency

BACKGROUND: Schizophrenia affects 1% of the population. Clozapine is the only medication licensed for treatment-resistant schizophrenia and is intensively monitored to prevent harm from neutropenia. Clozapine is also associated with increased risk of pneumonia although the mechanism is poorly unders...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ponsford, Mark, Castle, Daniel, Tahir, Tayyeb, Robinson, Rebecca, Wade, Wendy, Steven, Rachael, Bramhall, Kathryn, Moody, Mo, Carne, Emily, Ford, Catherine, Farewell, Daniel, Williams, Paul, El-Shanawany, Tariq, Jolles, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429246/ https://www.ncbi.nlm.nih.gov/pubmed/30259827 http://dx.doi.org/10.1192/bjp.2018.152

Ejemplares similares

Clinical and laboratory characteristics of clozapine-treated patients with schizophrenia referred to a national immunodeficiency clinic reveals a B-cell signature resembling common variable immunodeficiency (CVID)
por: Ponsford, Mark James, et al.
Publicado: (2020)

Increased Respiratory Viral Detection and Symptom Burden Among Patients with Primary Antibody Deficiency: Results from the BIPAD Study
por: Ponsford, Mark J., et al.
Publicado: (2021)

Development of a high-throughput SARS-CoV-2 antibody testing pathway using dried blood spot specimens
por: Moat, Stuart J, et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation and Vasculopathy Associated With STAT3-Dominant-Negative Hyper-IgE Syndrome
por: Ponsford, Mark J., et al.
Publicado: (2020)

Statistical methods in randomised controlled trials for delirium
por: Farewell, Daniel, et al.
Publicado: (2012)

COVID-19 Vaccine Uptake and Efficacy in a National Immunodeficiency Cohort
por: Ponsford, Mark J., et al.
Publicado: (2022)

Immunodeficient patient experience of emergency switch from intravenous to rapid push subcutaneous immunoglobulin replacement therapy during coronavirus disease 2019 shielding
por: Morgan, Clare, et al.
Publicado: (2022)

Calculated globulin (CG) as a screening test for antibody deficiency
por: Jolles, S, et al.
Publicado: (2014)

Clozapine reinitiation following a “red result” secondary to chemotherapy
por: Munshi, Tariq, et al.
Publicado: (2013)

Quantification of human C1 esterase inhibitor protein using an automated turbidimetric immunoassay
por: Tange, Clare E., et al.
Publicado: (2018)

Leukocytoclastic vasculitis secondary to clozapine
por: Mukherjee, Shatavisa, et al.
Publicado: (2019)

Clozapine: Drowsiness with markedly increased hypersalivation and myoclonus secondary to clozapine toxicity: case report
Publicado: (2021)

The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management
por: Patel, Smita Y., et al.
Publicado: (2019)

Clozapine Patients at the Interface between Primary and Secondary Care
por: Barrett, Marita, et al.
Publicado: (2018)

Burden of nosocomial COVID-19 in Wales: results from a multicentre retrospective observational study of 2508 hospitalised adults
por: Ponsford, Mark J, et al.
Publicado: (2021)

A Systematic Review and Meta-Analysis of Inpatient Mortality Associated With Nosocomial and Community COVID-19 Exposes the Vulnerability of Immunosuppressed Adults
por: Ponsford, Mark J., et al.
Publicado: (2021)

Burning pain secondary to clozapine use: a case report
por: Linton, Bradley, et al.
Publicado: (2014)

Clozapine: Functional decline secondary to drug intoxication: case report
Publicado: (2022)

The Prevalence of Electrocardiogram (ECG) Changes in Patients on Clozapine
por: Howson, Rachael, et al.
Publicado: (2022)

The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice
por: Manvich, Daniel F., et al.
Publicado: (2018)

Clozapine and Sweet's syndrome: case report
por: Bunting, Apphia, et al.
Publicado: (2023)

Clozapine in pregnancy
por: Sethi, Sujata
Publicado: (2006)

Clozapine is underutilized
por: Kane, John M.
Publicado: (2012)

Clozapine cessation
por: Ktari, H., et al.
Publicado: (2022)

Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice
por: Jendryka, Martin, et al.
Publicado: (2019)

An international clozapine titration guideline for clozapine: An opportunity for moving forward on personalizing clozapine treatment in India and other countries
por: de Leon, Jose
Publicado: (2022)

Atopic manifestations of inborn errors of immunity
por: Sams, Laura, et al.
Publicado: (2023)

Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Successful Clozapine Re-Challenge After Suspected Clozapine-Induced Myocarditis
por: Hosseini, Seyed Alireza, et al.
Publicado: (2020)

Correction to: Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
por: Tallantyre, E. C., et al.
Publicado: (2018)

Clozapine induced eosinophilia
por: Majumder, Pradipta, et al.
Publicado: (2011)

RISPERIDONE AUGMENTATION OF CLOZAPINE
por: Agarwal, Vivek
Publicado: (1999)

Clozapine: Current perspective
por: Solanki, Ram K., et al.
Publicado: (2007)

Clozapine associated thrombocytopenia
por: Kate, Natasha, et al.
Publicado: (2013)

Rhabdomyolysis in Clozapine Overdose
por: Jansman, Frank G. A., et al.
Publicado: (2015)

Clozapine for mitochondrial psychosis()
por: Finsterer, Josef, et al.
Publicado: (2017)

Clozapine-induced myocarditis
por: Datta, Tanuka, et al.
Publicado: (2018)

Clozapine Use in Adolescents
por: Praharaj, Samir Kumar
Publicado: (2017)

Clozapine-induced agranulocytosis
por: Mijovic, Aleksandar, et al.
Publicado: (2020)

Clozapine-induced seizure
por: Borah, Ankur Jyoti, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5ten4g7kgn8pc61hq34ttt2o9